Plain-English translation of NCT07650032 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new medical device called the Adagio System that uses freezing (cryoablation) to treat a serious heart rhythm problem called monomorphic ventricular tachycardia. This condition causes your heart to beat dangerously fast in a repetitive pattern. The study will measure whether this freezing procedure is safe and effective for patients whose symptoms haven't been controlled by medication alone.
Many patients with this dangerous heart rhythm problem don't respond well to anti-arrhythmia medications or have side effects that make them difficult to tolerate. This trial is testing whether the new freezing treatment can help these patients avoid future dangerous episodes.
You likely qualify if…
You likely don't qualify if…
You will undergo a cardiac ablation procedure using the new Adagio System's freezing technology to target and destroy the scar tissue causing your abnormal heart rhythm. The procedure is performed through catheters inserted into your heart, similar to other heart rhythm procedures. You will be required to attend baseline evaluations before the procedure and follow-up appointments afterward to monitor your safety and how well the treatment is working.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States